US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ProShares Ultra Nasdaq Biotechnology

116.60

+0.20700.18%

Pre-market: 117.831.23+1.06%08:59 EDT

Volume:10K

Turnover:1.13M

Market Cap:101.44M

PE:- -

High:116.74

Open:116.27

Low:113.31

Close:116.39

52wk High:126.40

52wk Low:55.34

Shares:870.00K

Float Shares:870.00K

Volume Ratio:0.88

T/O Rate:1.13%

Dividend:0.33

Dividend Rate:0.28%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Gilead CEO Daniel O’Day Sells 15,000 Common Shares Worth $1.96 Million

Gilead Says Q2 2026 Revenue Growth is Driven by Biktarvy, Descovy and Yeztugo Demand, Pricing Gains

Amgen Announces Availability of Q2 2026 Earnings Report Release

Amgen's Strong Second Quarter Drug Sales Drive Upward Forecast Revision and Early-Stage Weight Loss Drug Termination

Gilead Sciences Posts Net Loss as R&D Costs from Acquisitions Weigh on HIV Drug Revenue Growth

Gilead Sciences, Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Amgen Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Amgen Exec Says Continues to Expect Capital Expenditures of About $2.6 Billion in 2026 to Scale Manufacturing Capacity, Including for Maritide's Launch

THOMSON REUTERS

Amgen Exec Says Expect a Meaningful Sequential Increase in Operating Expenses in the Third Quarter

THOMSON REUTERS

Amgen Exec Says Spent $500 Million in Q2 on Capital Expenditures, Driven by Investments Across United States Manufacturing Sites-Conf Call

THOMSON REUTERS

Gilead Exec Says Saw a Softer Hiv Treatment Market in Q2 as People Fell Out of Insurance Plans Due to Eliminated Aca Tax Subsidies - Conf Call

THOMSON REUTERS

Gilead Exec Says Raising Full Year Hiv Growth Expectations to 9%-10% Year-over-Year from Prior Guidance of 8% Growth - Conf Call

THOMSON REUTERS

Gilead Exec Says Launch Preparations Fully Underway for Anito-Cel Cell Therapy, with Five Months to Go Until FDA Pdufa Date - Conf Call

THOMSON REUTERS

Gilead Exec Says Do not Currently Anticipate Pursuing Additional Sizable M&a Transactions This Year - Conf Call

THOMSON REUTERS

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Amgen Q2 FY26 GAAP EPS Rises 65% to $4.37; Revenue Increases 10% to $10.1 Billion

Amgen Inc Stock (AMGN) Closed Up by 3.03% on Aug 4: Key Drivers Unveiled

Gilead Sciences Inc Q2 Adjusted EPS USD -6.75 Vs. IBES Estimate USD -7.24

Gilead Posts a Loss on Acquisitions but Revenue Tells a Bigger Story

Gilead Q2 FY26 Loss Per Share Widens to $(8.45); Revenue Rises 10% to $7.8 Billion

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/BIB/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BIB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIB\",,,,,undefined,":{"symbol":"BIB","market":"US","secType":"STK","nameCN":"ProShares Ultra Nasdaq Biotechnology","latestPrice":116.5968,"timestamp":1788206400000,"preClose":116.3898,"halted":0,"volume":9835,"hourTrading":{"tag":"盘前","latestPrice":117.83,"preClose":116.5968,"latestTime":"08:59 EDT","volume":13,"amount":1531.79,"timestamp":1788267571078,"change":1.2332,"changeRate":0.010577,"amplitude":0},"delay":0,"changeRate":0.001778506363959796,"floatShares":870000,"shares":870000,"eps":0,"marketStatus":"Pre-Mkt","change":0.207,"latestTime":"09-01 09:10:53 EDT","open":116.27,"high":116.74,"low":113.31,"amount":1133602.00604,"amplitude":0.02947,"askPrice":118.64,"askSize":126,"bidPrice":113,"bidSize":10,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788269400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":116.5968,"sharesOutstanding":1040000,"nav":116.3208,"aum":101199096,"dividendRate":0.002795,"bidAskSpread":0.003041,"preHourTrading":{"tag":"盘前","latestPrice":117.83,"preClose":116.5968,"latestTime":"08:59 EDT","volume":13,"amount":1531.79,"timestamp":1788267571078,"change":1.2332,"changeRate":0.010577,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":116.6,"preClose":116.5968,"latestTime":"19:30 EDT","volume":13,"amount":1515.464,"timestamp":1788219002070,"change":0.0032,"changeRate":0.000027,"amplitude":0},"volumeRatio":0.8831875675581804,"impliedVol":0.4833,"impliedVolPercentile":0.761},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIB\",,,,,undefined,":{"symbol":"BIB","floatShares":870000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.8831875675581804,"shares":870000,"dividePrice":0.3259,"high":116.74,"amplitude":0.02947,"preClose":116.3898,"low":113.31,"week52Low":55.34,"pbRate":"--","week52High":126.399,"institutionHeld":0,"latestPrice":116.5968,"committee":-0.852941,"eps":0,"divideRate":0.002795,"volume":9835,"delay":0,"ttmEps":0,"open":116.27,"prevYearClose":79.7794,"prevWeekClose":116.3898,"prevMonthClose":116.5968,"prevQuarterClose":100.74,"fiveDayClose":120.906,"twentyDayClose":96.08,"sixtyDayClose":83.0787},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIB\",params:#limit:5,,,undefined,":[{"date":"2026-03-25","symbol":"BIB","amount":0.00714,"announcedDate":"2026-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-25","defaultRemindTime":1774445400000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-25","currency":"USD","dateTimestamp":1774411200000,"payDate":"2026-03-31"},{"date":"2025-12-24","symbol":"BIB","amount":0.134637,"announcedDate":"2025-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-24","defaultRemindTime":1766586600000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-24","currency":"USD","dateTimestamp":1766552400000,"payDate":"2025-12-31"},{"date":"2025-09-24","symbol":"BIB","amount":0.180541,"announcedDate":"2025-09-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-24","defaultRemindTime":1758720600000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-24","currency":"USD","dateTimestamp":1758686400000,"payDate":"2025-09-30"},{"date":"2025-06-25","symbol":"BIB","amount":0.170576,"announcedDate":"2025-06-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-25","defaultRemindTime":1750858200000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-25","currency":"USD","dateTimestamp":1750824000000,"payDate":"2025-07-01"},{"date":"2025-03-26","symbol":"BIB","amount":0.130939,"announcedDate":"2025-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-26","defaultRemindTime":1742995800000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-26","currency":"USD","dateTimestamp":1742961600000,"payDate":"2025-04-01"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIB\",market:\"US\",,,undefined,":[{"executeDate":"2022-12-22","recordDate":"2022-12-23","paymentDate":"2022-12-30","value":0.019852,"currency":"USD"},{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-28","value":0.038393,"currency":"USD"},{"executeDate":"2024-03-20","recordDate":"2024-03-21","paymentDate":"2024-03-27","value":0.040324,"currency":"USD"},{"executeDate":"2024-06-26","recordDate":"2024-06-26","paymentDate":"2024-07-03","value":0.26476,"currency":"USD"},{"executeDate":"2024-09-25","recordDate":"2024-09-25","paymentDate":"2024-10-02","value":0.15285,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BIB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BIB\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657560034","title":"Gilead CEO Daniel O’Day Sells 15,000 Common Shares Worth $1.96 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657560034","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657560034?lang=en_us&edition=fundamental","pubTime":"2026-08-05 06:11","pubTimestamp":1785881462,"startTime":"0","endTime":"0","summary":"Gilead CEO Daniel O’Day sells 15,000 common shares worth $1.96 millionGilead Chairman and CEO Daniel Patrick O’Day sold 15,000 common shares on Aug. 3.Sales priced between USD 129.66 and USD 131.34 pe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDLb6Xl7Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Gilead CEO Daniel O’Day Sells 15,000 Common Shares Worth $1.96 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","MEDI","TBXU","LU0889565916.HKD","LU1066051498.USD","BBH","GILD","BK4532","IE00B19Z3581.USD","LU0965509283.SGD","IE00BSNM7G36.USD","IBBQ","LU1061106388.HKD","LU0320765992.SGD","BK4568","IE00B3T34201.USD","LU1430594728.SGD","LU0234570918.USD","LU0882574055.USD","IBB","LU1674673428.USD","LU0823416689.USD","LU1057294990.SGD","LU2112291526.USD","LU1778281490.HKD","IE00BZ1G4Q59.USD","LU0114720955.EUR","LU1934455194.USD","BK4139","SG9999015986.USD","IE00B7SZLL34.SGD","LU2324357040.USD","LU2089984988.USD","BIB","LU1934455863.HKD","LU1585245621.USD","LU1571399168.USD","LU0965508806.USD","LU1934455277.USD","LU0058720904.USD","LU2468319806.SGD","LU0109394709.USD","BMED","LU1037948897.HKD","IE0002270589.USD","LU0965509010.AUD","SG9999015952.SGD","LU1674673691.USD","TMED","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657560620","title":"Gilead Says Q2 2026 Revenue Growth is Driven by Biktarvy, Descovy and Yeztugo Demand, Pricing Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2657560620","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657560620?lang=en_us&edition=fundamental","pubTime":"2026-08-05 05:45","pubTimestamp":1785879934,"startTime":"0","endTime":"0","summary":"Gilead says Q2 2026 revenue growth is driven by Biktarvy, Descovy and Yeztugo demand, pricing gainsGilead posted Q2 2026 revenue of $7.8 billion, driven by HIV growth, led by Biktarvy demand and pricing.HIV sales rose 12% to $5.69 billion; Biktarvy increased 7% to $3.77 billion, supported by channel mix and inventory build.PrEP sales more than doubled to $1.03 billion; Descovy for PrEP rose 60% to $801 million, Yeztugo reached $232 million.Liver disease sales climbed 10% to $877 million on higher demand in PBC, HBV, HDV, partly offset by fewer HCV starts.Full-year product sales guidance rose to $30.1 billion-$30.4 billion; HIV growth outlook increased to 9%-10%.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gilead Sciences Inc. publish","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDLk8bB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","SG9999015945.SGD","IE00BSNM7G36.USD","LU0965509010.AUD","LU2089984988.USD","LU1037948897.HKD","BK4568","LU0058720904.USD","LU0320765992.SGD","LU1571399168.USD","LU1585245621.USD","LU1674673428.USD","LU2112291526.USD","LU0882574055.USD","IBB","LU1934455863.HKD","MEDI","TMED","BK4139","BK4532","LU1934455194.USD","IE00B19Z3581.USD","LU1057294990.SGD","BBH","LU0289739699.SGD","IE00B3T34201.USD","LU1066051498.USD","BK4583","IE0002270589.USD","TBXU","BMED","IE00B7SZLL34.SGD","LU0109394709.USD","IBBQ","LU0965509101.SGD","SG9999015986.USD","BK4585","LU0122379950.USD","SG9999015978.USD","LU0965508806.USD","IE00BZ1G4Q59.USD","LU2324357040.USD","GILD","LU1066053197.SGD","LU0889565916.HKD","BK4566","LU2468319806.SGD","LU1674673691.USD","LU1037948541.HKD","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657605965","title":"Amgen Announces Availability of Q2 2026 Earnings Report Release","url":"https://stock-news.laohu8.com/highlight/detail?id=2657605965","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657605965?lang=en_us&edition=fundamental","pubTime":"2026-08-05 05:41","pubTimestamp":1785879702,"startTime":"0","endTime":"0","summary":"Amgen announces availability of Q2 2026 earnings report releaseAmgen published its fiscal 2026 second-quarter earnings press release: .Six key growth drivers rose 26% year over year, representing nearly 70% of second-quarter product sales.Investor conference call event page: .Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amgen Inc. published the original content used to generate this news brief on August 04, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDLbMTq0p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","LU2089984988.USD","BBH","IBBQ","IE00BJJMRZ35.SGD","LU0058720904.USD","LU0289739699.SGD","BK4599","LU1571399168.USD","IE00BJT1NW94.SGD","IBB","LU1023059063.AUD","PBE","BK4534","TBXU","LU1983299246.USD","SG9999001440.SGD","BK4585","PJP","LU0122379950.USD","BIB","BK4581","LU2468319806.SGD","BK4533","BK4588","LU0109394709.USD","LU1061106388.HKD","IE00BFTCPJ56.SGD","LU0320765992.SGD","LU0868494617.USD","LU2242652126.USD","LU2112291526.USD","LU2242646821.SGD","LU0889565916.HKD","LU1057294990.SGD","IE00B2B36J28.USD","IE0009355771.USD","AMGN","IE0002141913.USD","BK4139","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184959126","title":"Amgen's Strong Second Quarter Drug Sales Drive Upward Forecast Revision and Early-Stage Weight Loss Drug Termination","url":"https://stock-news.laohu8.com/highlight/detail?id=1184959126","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184959126?lang=en_us&edition=fundamental","pubTime":"2026-08-05 05:21","pubTimestamp":1785878467,"startTime":"0","endTime":"0","summary":"Amgen reported its second-quarter earnings after the U.S. stock market close on Tuesday, with robust drug sales boosting profits, leading the company to raise its full-year outlook. However, it also...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","IE00B2B36J28.USD","AMGN","PINK","IE0002141913.USD","LU2112291526.USD","LU1023059063.AUD","XLVI","IBBQ","IYH","LU1571399168.USD","PJP","RSPH","BBH","TBXU","FHLC","BIB","BK4588","IE00BJT1NW94.SGD","MEDI","FXH","IE00BFTCPJ56.SGD","LU2242646821.SGD","IE00B4R5TH58.HKD","IBB","LU0058720904.USD","LU0122379950.USD","TRUH","LU0289739699.SGD","LU2468319806.SGD","BK4599","LU1983299246.USD","IE00BJJMRZ35.SGD","THNR","IE0009355771.USD","LU0889565916.HKD","BK4139","LU1057294990.SGD","PBE","LU0109394709.USD","LU0320765992.SGD","LU1061106388.HKD","LU0868494617.USD","NVOC","BK4533","CURE","BK4581","NBDS","SG9999001440.SGD","LU2089984988.USD","BK4566","BK4585","LU2242652126.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106548725","title":"Gilead Sciences Posts Net Loss as R&D Costs from Acquisitions Weigh on HIV Drug Revenue Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=1106548725","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106548725?lang=en_us&edition=fundamental","pubTime":"2026-08-05 05:10","pubTimestamp":1785877818,"startTime":"0","endTime":"0","summary":"Gilead Sciences Inc reported a second-quarter net loss on Tuesday after the market close, as revenue growth driven by higher HIV product sales was offset by significant new research and development...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","IE00B19Z3B42.SGD","LU0109394709.USD","LU1934455277.USD","LU2089984988.USD","GILD","LU0882574055.USD","SG9999015952.SGD","BK4550","LU0058720904.USD","LU0122379950.USD","LU0234570918.USD","LU1023059063.AUD","BK4583","LU1037948897.HKD","LU1066053197.SGD","BK4139","LU1674673691.USD","LU0965509010.AUD","BK4566","LU0114720955.EUR","LU0823416689.USD","IE00B7SZLL34.SGD","LU1066051498.USD","LU2087621335.USD","LU1571399168.USD","LU2468319806.SGD","IE00BSNM7G36.USD","IE00BZ1G4Q59.USD","LU0861579265.USD","MEDI","LU1778281490.HKD","TBXU","LU1061106388.HKD","LU0889565916.HKD","LU0965508806.USD","LU0965509283.SGD","LU1934455194.USD","LU1839511570.USD","LU1934455863.HKD","LU0289739699.SGD","BK4532","IBBQ","IBB","LU0320765992.SGD","LU0965509101.SGD","LU1674673428.USD","BK4568","SG9999015978.USD","LU1430594728.SGD","SG9999015945.SGD","IE0002270589.USD","LU1057294990.SGD","LU2112291526.USD","SG9999015986.USD","IE00BKVL7J92.USD","TMED","IE00B3T34201.USD","IE00B19Z3581.USD","BK4585","LU1037948541.HKD","BBH","LU1585245621.USD","BK4588","BK4578","BMED","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657567873","title":"Gilead Sciences, Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657567873","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657567873?lang=en_us&edition=fundamental","pubTime":"2026-08-05 05:01","pubTimestamp":1785877314,"startTime":"0","endTime":"0","summary":"Gilead Sciences, Inc reports results for the quarter ended June 30 - Earnings SummaryGilead Sciences, IncGILD.OQreported a quarterly adjusted loss of $6.75 per share for the quarter ended June 30, low","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL8N44134O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4550","IE00BZ1G4Q59.USD","LU0114720955.EUR","TBXU","BBH","LU2324357040.USD","BMED","BK4568","LU1023059063.AUD","LU1037948541.HKD","IBB","LU1674673691.USD","LU1066051498.USD","SG9999015952.SGD","GILD","LU0882574055.USD","LU0058720904.USD","TMED","IBBQ","LU0889565916.HKD","IE0002270589.USD","MEDI","LU1430594728.SGD","LU0234570918.USD","LU1571399168.USD","LU0289739699.SGD","BK4566","LU0965509283.SGD","LU1934455863.HKD","LU1066053197.SGD","IE00BSNM7G36.USD","LU1839511570.USD","BK4139","BK4583","LU0122379950.USD","LU1934455277.USD","LU1037948897.HKD","LU2089984988.USD","LU0965509010.AUD","LU2112291526.USD","BK4578","LU1585245621.USD","LU0109394709.USD","IE00B19Z3B42.SGD","BIB","LU0320765992.SGD","LU1061106388.HKD","BK4532","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657678035","title":"Amgen Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657678035","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657678035?lang=en_us&edition=fundamental","pubTime":"2026-08-05 05:01","pubTimestamp":1785877288,"startTime":"0","endTime":"0","summary":"Amgen Inc reports results for the quarter ended June 30 - Earnings SummaryAmgen IncAMGN.OQreported quarterly adjusted earnings of $6.29 per share for the quarter ended June 30, higher than the same qu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL8N441345:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242646821.SGD","LU0122379950.USD","BK4139","PBE","IBB","LU0889565916.HKD","LU0289739699.SGD","LU0109394709.USD","BK4566","IE0009355771.USD","LU2089984988.USD","IE00BFTCPJ56.SGD","SG9999001440.SGD","LU2112291526.USD","TBXU","LU0058720904.USD","IE0002141913.USD","BIB","LU0868494617.USD","IBBQ","AMGN","IE00B2B36J28.USD","BBH","LU1571399168.USD","BK4581","LU0320765992.SGD","BK4534","PJP","LU2468319806.SGD","BK4585","LU1023059063.AUD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU1983299246.USD","IE00B4R5TH58.HKD","LU1061106388.HKD","BK4588","BK4533","LU2242652126.USD","LU1057294990.SGD","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657620875","title":"Amgen Exec Says Continues to Expect Capital Expenditures of About $2.6 Billion in 2026 to Scale Manufacturing Capacity, Including for Maritide's Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2657620875","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657620875?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:59","pubTimestamp":1785877161,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nFWN4411FW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBBQ","LU1571399168.USD","IE0002141913.USD","BK4533","IE00BJT1NW94.SGD","SG9999001440.SGD","BK4534","LU2112291526.USD","BK4588","LU0122379950.USD","LU2089984988.USD","PBE","BBH","PJP","LU0109394709.USD","IE00BJJMRZ35.SGD","LU1983299246.USD","LU1057294990.SGD","LU0889565916.HKD","BK4599","LU2468319806.SGD","IE00BFTCPJ56.SGD","LU2242652126.USD","LU1023059063.AUD","IE00B4R5TH58.HKD","LU0868494617.USD","BK4139","BIB","TBXU","LU1061106388.HKD","IE0009355771.USD","BK4581","LU0289739699.SGD","BK4566","IBB","BK4585","LU2242646821.SGD","AMGN","LU0320765992.SGD","IE00B2B36J28.USD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657567892","title":"Amgen Exec Says Expect a Meaningful Sequential Increase in Operating Expenses in the Third Quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=2657567892","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657567892?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:59","pubTimestamp":1785877161,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nFWN4411FW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0320765992.SGD","BK4534","AMGN","PBE","BK4139","IE0002141913.USD","IE00B4R5TH58.HKD","LU2112291526.USD","PJP","TBXU","BK4585","LU2242652126.USD","LU0889565916.HKD","BBH","IBBQ","LU1057294990.SGD","BIB","BK4566","BK4599","LU2242646821.SGD","BK4581","IE0009355771.USD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","LU1983299246.USD","BK4533","IE00B2B36J28.USD","LU0868494617.USD","LU1571399168.USD","LU0122379950.USD","BK4588","LU2468319806.SGD","LU2089984988.USD","IBB","IE00BJT1NW94.SGD","LU0109394709.USD","LU0289739699.SGD","LU1023059063.AUD","LU0058720904.USD","SG9999001440.SGD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657562278","title":"Amgen Exec Says Spent $500 Million in Q2 on Capital Expenditures, Driven by Investments Across United States Manufacturing Sites-Conf Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2657562278","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657562278?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:59","pubTimestamp":1785877161,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nFWN4411FW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BJJMRZ35.SGD","LU1571399168.USD","LU2112291526.USD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","BK4599","LU2242652126.USD","IE0009355771.USD","BIB","IBBQ","BBH","LU2468319806.SGD","LU0122379950.USD","PBE","BK4566","LU0320765992.SGD","LU2089984988.USD","LU0868494617.USD","BK4581","LU0058720904.USD","LU1061106388.HKD","BK4534","LU0109394709.USD","AMGN","IE00B4R5TH58.HKD","LU1023059063.AUD","LU1983299246.USD","LU2242646821.SGD","SG9999001440.SGD","LU0289739699.SGD","LU0889565916.HKD","TBXU","IE00BFTCPJ56.SGD","BK4585","BK4588","IBB","PJP","BK4139","IE0002141913.USD","BK4533","LU1057294990.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657881560","title":"Gilead Exec Says Saw a Softer Hiv Treatment Market in Q2 as People Fell Out of Insurance Plans Due to Eliminated Aca Tax Subsidies - Conf Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2657881560","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657881560?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:36","pubTimestamp":1785875810,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nFWN4411CY:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1066053197.SGD","IE00BSNM7G36.USD","BK4566","LU2468319806.SGD","BK4585","IE0002270589.USD","SG9999015986.USD","BK4532","IE00B3T34201.USD","TBXU","LU0058720904.USD","LU0965508806.USD","GILD","LU2324357040.USD","LU1934455194.USD","TMED","BIB","BMED","IE00B19Z3581.USD","LU0889565916.HKD","IE00B7SZLL34.SGD","LU0882574055.USD","LU1066051498.USD","BBH","SG9999015945.SGD","IBBQ","LU0122379950.USD","LU0965509101.SGD","LU1934455863.HKD","LU2089984988.USD","LU1674673691.USD","LU1571399168.USD","LU1037948541.HKD","LU0114720955.EUR","MEDI","LU1585245621.USD","LU0289739699.SGD","LU1674673428.USD","LU0109394709.USD","LU0965509010.AUD","IE00BZ1G4Q59.USD","LU1057294990.SGD","BK4139","IBB","BK4568","SG9999015978.USD","LU1037948897.HKD","LU2112291526.USD","BK4583","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657564733","title":"Gilead Exec Says Raising Full Year Hiv Growth Expectations to 9%-10% Year-over-Year from Prior Guidance of 8% Growth - Conf Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2657564733","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657564733?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:36","pubTimestamp":1785875810,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nFWN4411CY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0889565916.HKD","BK4532","LU1066053197.SGD","LU1571399168.USD","SG9999015952.SGD","SG9999015945.SGD","LU1674673691.USD","LU1934455277.USD","IE00BKVL7J92.USD","BMED","TMED","IBB","IE00B19Z3B42.SGD","LU0965509283.SGD","LU1037948897.HKD","BIB","BK4568","GILD","BK4578","LU2089984988.USD","MEDI","LU0122379950.USD","BBH","IBBQ","LU0289739699.SGD","LU1066051498.USD","LU1061106388.HKD","LU0882574055.USD","TBXU","IE00B3T34201.USD","BK4583","LU1037948541.HKD","SG9999015978.USD","LU0861579265.USD","LU1778281490.HKD","LU2468319806.SGD","LU1839511570.USD","LU0114720955.EUR","LU1057294990.SGD","LU1934455194.USD","BK4588","IE00BZ1G4Q59.USD","BK4139","IE00BSNM7G36.USD","LU0965508806.USD","LU2112291526.USD","LU1430594728.SGD","LU0965509010.AUD","LU0058720904.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657562399","title":"Gilead Exec Says Launch Preparations Fully Underway for Anito-Cel Cell Therapy, with Five Months to Go Until FDA Pdufa Date - Conf Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2657562399","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657562399?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:36","pubTimestamp":1785875810,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nFWN4411CY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4566","IE00B7SZLL34.SGD","LU0882574055.USD","LU1571399168.USD","LU0965509010.AUD","IE0002270589.USD","IE00BZ1G4Q59.USD","IE00B19Z3B42.SGD","BK4532","LU0320765992.SGD","SG9999015986.USD","GILD","BK4568","SG9999015978.USD","LU1037948897.HKD","LU1057294990.SGD","LU1430594728.SGD","IBB","IBBQ","IE00B19Z3581.USD","LU0965508806.USD","LU0234570918.USD","LU0823416689.USD","LU0889565916.HKD","IE00B3T34201.USD","LU2087621335.USD","BK4588","LU1037948541.HKD","SG9999015945.SGD","IE00BSNM7G36.USD","LU1839511570.USD","TMED","LU2468319806.SGD","LU1066053197.SGD","BK4578","LU0114720955.EUR","TBXU","BMED","LU2089984988.USD","LU0122379950.USD","LU0058720904.USD","BBH","SG9999015952.SGD","BIB","LU1066051498.USD","IE00BKVL7J92.USD","BK4550","BK4583","MEDI","LU0965509283.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657356795","title":"Gilead Exec Says Do not Currently Anticipate Pursuing Additional Sizable M&a Transactions This Year - Conf Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2657356795","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657356795?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:36","pubTimestamp":1785875810,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nFWN4411CY:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1066053197.SGD","LU2089984988.USD","LU1934455863.HKD","TMED","BK4550","LU1934455277.USD","BK4585","LU1674673691.USD","LU1037948541.HKD","LU0122379950.USD","BBH","SG9999015986.USD","BK4578","SG9999015952.SGD","LU0965508806.USD","SG9999015945.SGD","IE00BSNM7G36.USD","LU0320765992.SGD","LU0234570918.USD","BIB","SG9999015978.USD","LU2468319806.SGD","LU0965509283.SGD","BK4588","IE00B19Z3B42.SGD","LU0889565916.HKD","IE00B19Z3581.USD","LU1778281490.HKD","IE00BZ1G4Q59.USD","IBB","LU1057294990.SGD","LU2087621335.USD","MEDI","BK4532","LU1934455194.USD","LU1674673428.USD","LU0882574055.USD","IBBQ","LU1061106388.HKD","BMED","LU0823416689.USD","LU1839511570.USD","LU0289739699.SGD","IE00BKVL7J92.USD","BK4566","TBXU","GILD","LU0861579265.USD","LU1066051498.USD","LU0965509010.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657562688","title":"Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2657562688","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657562688?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:36","pubTimestamp":1785875760,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  advanced 3.13% to $135.25 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 1.79% to 7,736.52 and the Dow Jones Industrial Average  rising 1.71% to 54,085.88.This was the stock's second consecutive day of gains.Gilead Sciences Inc. closed 14.01% below its 52-week high of $157.29, which the company reached on February 11th.The stock outperformed some of its competitors Tuesday, as Johnson & Johnson  rose 0.20% to $254.93, Pfizer Inc.  rose 1.52% to $25.41, and Abbott Laboratories  fell 1.55% to $105.46.Trading volume  eclipsed its 50-day average volume of 7.9 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 4, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","GILD","LU1934455194.USD","LU1066051498.USD","BK4139","LU0861579265.USD","LU2087621335.USD","LU2112291526.USD","LU0965509010.AUD","LU2324357040.USD","TBXU","BK4585","IE00B7SZLL34.SGD","LU1839511570.USD","LU1674673691.USD","LU0889565916.HKD","BBH","IBBQ","SG9999015952.SGD","IE00B3T34201.USD","LU1057294990.SGD","LU1430594728.SGD","BK4583","IE00B19Z3B42.SGD","BIB","SG9999015986.USD","MEDI","IE00B19Z3581.USD","BK4568","LU1037948541.HKD","IE00BKVL7J92.USD","LU1037948897.HKD","LU0114720955.EUR","LU0823416689.USD","LU0965509101.SGD","BMED","LU0965509283.SGD","LU1934455863.HKD","BK4566","IE0002270589.USD","LU0965508806.USD","IE00BSNM7G36.USD","LU1585245621.USD","IE00BZ1G4Q59.USD","SG9999015978.USD","BK4578","LU1571399168.USD","LU1778281490.HKD","LU1934455277.USD","BK4550","LU0122379950.USD","BK4532","BK4588","LU1066053197.SGD","LU0882574055.USD","LU2468319806.SGD","LU0234570918.USD","LU1674673428.USD","LU2089984988.USD","IBB","LU0109394709.USD","LU0289739699.SGD","LU1023059063.AUD","LU0058720904.USD","LU1061106388.HKD","TMED","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657648445","title":"Amgen Q2 FY26 GAAP EPS Rises 65% to $4.37; Revenue Increases 10% to $10.1 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2657648445","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657648445?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:23","pubTimestamp":1785875005,"startTime":"0","endTime":"0","summary":"Amgen Q2 FY26 GAAP EPS rises 65% to $4.37; revenue increases 10% to $10.1 billionAmgen Q2 2026 revenue rose 10% to $10.1 billion; GAAP diluted EPS jumped 65% to $4.37.GAAP operating income climbed to ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDL8qt5Pf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","PJP","LU0109394709.USD","IBBQ","LU1061106388.HKD","LU1983299246.USD","BK4585","BIB","BK4566","LU0289739699.SGD","BK4588","IE00B2B36J28.USD","LU0058720904.USD","LU1023059063.AUD","AMGN","IE0002141913.USD","PBE","SG9999001440.SGD","IE00BFTCPJ56.SGD","BK4139","IE00BJJMRZ35.SGD","BK4533","LU2242652126.USD","BK4581","LU2468319806.SGD","LU0320765992.SGD","BK4599","LU0122379950.USD","LU1571399168.USD","IE0009355771.USD","IBB","LU1057294990.SGD","BBH","TBXU","LU2112291526.USD","BK4534","LU0889565916.HKD","LU0868494617.USD","IE00BJT1NW94.SGD","LU2242646821.SGD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657456440","title":"Amgen Inc Stock (AMGN) Closed Up by 3.03% on Aug 4: Key Drivers Unveiled","url":"https://stock-news.laohu8.com/highlight/detail?id=2657456440","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657456440?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:15","pubTimestamp":1785874544,"startTime":"0","endTime":"0","summary":"• Amgen reported second-quarter earnings exceeding consensus estimates for revenue and earnings per share.\n• Positive interim clinical data for a metabolic health candidate drove share price appreciation.\n• Annual revenue reached $36.75 billion with the company ranking tenth in net profit.","market":"other","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262074397-market-movers-amgn-20260804","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","PJP","SG9999001440.SGD","LU0320765992.SGD","LU2242646821.SGD","BK4585","BIB","IE0002141913.USD","TBXU","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU1571399168.USD","IE00BJJMRZ35.SGD","BK4599","LU1061106388.HKD","IBB","BBH","LU0868494617.USD","LU1023059063.AUD","LU1983299246.USD","LU2242652126.USD","LU0889565916.HKD","LU2112291526.USD","LU0109394709.USD","BK4139","BK4581","LU0058720904.USD","LU0122379950.USD","BK4588","BK4566","IE00BJT1NW94.SGD","BK4534","LU2089984988.USD","AMGN","BK4533","IBBQ","IE0009355771.USD","LU1057294990.SGD","LU0289739699.SGD","PBE","IE00B2B36J28.USD","04332"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657561614","title":"Gilead Sciences Inc Q2 Adjusted EPS USD -6.75 Vs. IBES Estimate USD -7.24","url":"https://stock-news.laohu8.com/highlight/detail?id=2657561614","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657561614?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:14","pubTimestamp":1785874454,"startTime":"0","endTime":"0","summary":"Aug 04 (Reuters) - Gilead Sciences Inc Q2 product sales USD 7,627 million.:((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))Source Date/Time = 04-AUG-202617:45:00.077 GMT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nRSD92qDLL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ1G4Q59.USD","LU2112291526.USD","TMED","LU0058720904.USD","BK4532","BK4568","LU1066053197.SGD","BK4588","LU1934455194.USD","LU0114720955.EUR","LU0109394709.USD","LU2468319806.SGD","BK4139","LU2089984988.USD","MEDI","SG9999015952.SGD","IE00BSNM7G36.USD","LU0889565916.HKD","LU0965509010.AUD","LU0122379950.USD","SG9999015945.SGD","TBXU","LU1037948541.HKD","LU1037948897.HKD","IBB","LU1674673691.USD","LU1934455277.USD","LU1061106388.HKD","LU1778281490.HKD","BK4583","IBBQ","GILD","LU0965509283.SGD","LU1057294990.SGD","LU1430594728.SGD","BMED","IE00BKVL7J92.USD","BIB","BK4578","LU0965508806.USD","IE00B3T34201.USD","BBH","LU0882574055.USD","LU1839511570.USD","LU0289739699.SGD","IE00B19Z3B42.SGD","LU0861579265.USD","LU1571399168.USD","SG9999015978.USD","LU1066051498.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657456136","title":"Gilead Posts a Loss on Acquisitions but Revenue Tells a Bigger Story","url":"https://stock-news.laohu8.com/highlight/detail?id=2657456136","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657456136?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:12","pubTimestamp":1785874320,"startTime":"0","endTime":"0","summary":"Even as dealmaking costs drove Gilead Sciences to a second-quarter loss, the company delivered double-digit revenue growth on the back of its market-leading HIV franchise.Total revenue jumped 10% to $","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1037948897.HKD","SG9999015978.USD","LU2087621335.USD","LU1057294990.SGD","IE00B19Z3B42.SGD","LU2468319806.SGD","IE00BKVL7J92.USD","LU1778281490.HKD","LU1839511570.USD","LU1934455194.USD","LU0965509101.SGD","LU0882574055.USD","LU0965508806.USD","BK4578","BK4583","IBB","LU0965509010.AUD","LU1934455863.HKD","TBXU","LU0823416689.USD","LU1585245621.USD","IE00B3T34201.USD","LU1430594728.SGD","LU2324357040.USD","MEDI","LU0289739699.SGD","LU0234570918.USD","LU0320765992.SGD","SG9999015986.USD","LU1571399168.USD","LU1674673428.USD","SG9999015952.SGD","GILD","BK4588","BMED","BK4568","LU1023059063.AUD","LU0122379950.USD","BK4550","LU0058720904.USD","LU0861579265.USD","LU2089984988.USD","BIB","IE00B7SZLL34.SGD","LU1061106388.HKD","BK4139","LU0109394709.USD","LU2112291526.USD","IBBQ","IE00BSNM7G36.USD","LU0965509283.SGD","BK4532","LU1066053197.SGD","LU1674673691.USD","LU0114720955.EUR","LU1066051498.USD","TMED","IE00B19Z3581.USD","IE0002270589.USD","BK4585","LU0889565916.HKD","SG9999015945.SGD","BK4566","LU1037948541.HKD","LU1934455277.USD","IE00BZ1G4Q59.USD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657569789","title":"Gilead Q2 FY26 Loss Per Share Widens to $(8.45); Revenue Rises 10% to $7.8 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2657569789","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657569789?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:09","pubTimestamp":1785874155,"startTime":"0","endTime":"0","summary":"Gilead Q2 FY26 loss per share widens to $(8.45); revenue rises 10% to $7.8 billionGilead posted Q2 2026 revenue up 10% to USD 7.8 billion, while diluted EPS swung to a loss of USD 8.45.Acquired in-pro","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDL9STQkM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","LU0882574055.USD","LU1571399168.USD","LU1674673691.USD","LU0965509010.AUD","IE0002270589.USD","LU1023059063.AUD","IE00BZ1G4Q59.USD","IE00B19Z3B42.SGD","LU0109394709.USD","BK4532","LU0320765992.SGD","GILD","BK4568","LU1037948897.HKD","LU0289739699.SGD","LU1430594728.SGD","IBB","IBBQ","LU0234570918.USD","BK4585","LU0889565916.HKD","BK4588","LU1037948541.HKD","LU2112291526.USD","IE00BSNM7G36.USD","BK4139","LU1839511570.USD","TMED","LU1066053197.SGD","BK4578","LU0114720955.EUR","TBXU","LU1061106388.HKD","BMED","LU1934455277.USD","LU2089984988.USD","LU0122379950.USD","LU1585245621.USD","LU0058720904.USD","BBH","SG9999015952.SGD","BIB","LU1066051498.USD","BK4550","LU1934455863.HKD","BK4583","MEDI","LU2324357040.USD","LU0965509283.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}